Journey of TRAIL from bench to bedside and its potential role in immuno-oncology
Induction of apoptosis in cancer cells has increasingly been the focus of many therapeutic approaches in oncology field. Since its identification as a TNF family member, TRAIL (TNF-related apoptosis-inducing ligand) paved a new path in apoptosis inducing cancer therapies. Its selective ability to ac...
Main Authors: | George E. Naoum, Donald J. Buchsbaum, Fady Tawadros, Ammad Farooqi, Waleed O. Arafat |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2017-04-01
|
Series: | Oncology Reviews |
Subjects: | |
Online Access: | http://www.oncologyreviews.org/index.php/or/article/view/332 |
Similar Items
-
Association between breast cancer and tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) gene 1595C/T SNP in a Pakistani population
by: Saima F. Rehman, et al.
Published: (2015-12-01) -
TRAIL-R1 and TRAIL-R2 Mediate TRAIL-Dependent Apoptosis in Activated Primary Human B Lymphocytes
by: Julian Staniek, et al.
Published: (2019-04-01) -
Trailing TRAIL Resistance: Novel Targets for TRAIL sensitization in Cancer cells
by: RACHANA eTRIVEDI, et al.
Published: (2015-04-01) -
Natural Product Mediated Regulation of Death Receptors and Intracellular Machinery: Fresh from the Pipeline about TRAIL-Mediated Signaling and Natural TRAIL Sensitizers
by: Durray Shahwar, et al.
Published: (2019-04-01) -
TRAIL/NF-κB/CX3CL1 Mediated Onco-Immuno Crosstalk Leading to TRAIL Resistance of Pancreatic Cancer Cell Lines
by: Claudia Geismann, et al.
Published: (2018-06-01)